For: | Morscio J, Tousseyn T. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders. World J Transplant 2016; 6(3): 505-516 [PMID: 27683629 DOI: 10.5500/wjt.v6.i3.505] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v6/i3/505.htm |
Number | Citing Articles |
1 |
Chi Yuen Cheung, Wing Hung Lau, Wah Cheuk. Epstein-Barr Virus–Associated Nodal Marginal Zone Lymphoma: Part of the Spectrum of Posttransplant Lymphoproliferative Disorder?. International Journal of Surgical Pathology 2019; 27(1): 94 doi: 10.1177/1066896918784184
|
2 |
Ayumi Fujimoto, Ritsuro Suzuki. Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes. Cancers 2020; 12(2): 328 doi: 10.3390/cancers12020328
|
3 |
Ingrid H Penzhorn, Johann W Schneider, Candice Sher-Locketz. The Prevalence of Epstein-Barr Virus in Plasma Cell Neoplasms is Higher in HIV-Positive Individuals. International Journal of Surgical Pathology 2023; 31(5): 564 doi: 10.1177/10668969221113490
|
4 |
Irina Margaritescu, Aurel-Doru Chirita, Kristen Addis, Matthew S. Dinehart, Sarah Carlock, Mallory Shiver Abate, Bruce R. Smoller. Atlas of Dermatology, Dermatopathology and Venereology. 2020; : 1 doi: 10.1007/978-3-319-45134-3_83-1
|
5 |
Duaa AbdelHameid, Anthony Felice, Lauren B. Cooper, Shalika B. Katugaha. Long‐term remission in an adult heart transplant recipient with advanced Burkitt’s lymphoma post‐transplant lymphoproliferative disorder after anthracycline‐free chemotherapy: A case report and literature review. Transplant Infectious Disease 2020; 22(4) doi: 10.1111/tid.13265
|
6 |
Jonathan R Kerr. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors. Journal of Clinical Pathology 2019; 72(10): 651 doi: 10.1136/jclinpath-2019-205822
|
7 |
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain, Anthea C Peters. Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders. Clinical Lymphoma Myeloma and Leukemia 2022; 22(10): 744 doi: 10.1016/j.clml.2022.05.006
|
8 |
Rabea Asleh, Darko Vucicevic, Tanya M. Petterson, Walter K. Kremers, Naveen L. Pereira, Richard C. Daly, Brooks S. Edwards, D. Eric Steidley, Robert L. Scott, Sudhir S. Kushwaha. Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. Journal of Clinical Medicine 2022; 11(2): 322 doi: 10.3390/jcm11020322
|
9 |
Mathis Overkamp, Massimo Granai, Irina Bonzheim, Julia Steinhilber, Jens Schittenhelm, Wolfgang Bethge, Leticia Quintanilla-Martinez, Falko Fend, Birgit Federmann. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Virchows Archiv 2021; 478(6): 1135 doi: 10.1007/s00428-020-02985-4
|
10 |
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology. 2020; : 1729 doi: 10.1007/978-3-319-96681-6_17
|
11 |
Heather Tillman, Peter Vogel, Tiffani Rogers, Walter Akers, Jerold E. Rehg. Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors. Veterinary Pathology 2020; 57(3): 445 doi: 10.1177/0300985820913265
|
12 |
Britta Maecker-Kolhoff, Kais Hussein, Stephen Gottschalk. Pediatric Liver Transplantation. 2021; : 265 doi: 10.1016/B978-0-323-63671-1.00028-8
|
13 |
Upton D. Allen, Jutta K. Preiksaitis. Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation 2019; 33(9) doi: 10.1111/ctr.13652
|
14 |
由 李. Research Progress on EBV Reactivation. Advances in Clinical Medicine 2024; 14(03): 467 doi: 10.12677/ACM.2024.143725
|
15 |
Steven H. Swerdlow, Steven A. Webber. Post-Transplant Lymphoproliferative Disorders. 2021; : 9 doi: 10.1007/978-3-030-65403-0_2
|
16 |
Lukas Marcelis, Thomas Tousseyn. The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders. Cancer Microenvironment 2019; 12(1): 3 doi: 10.1007/s12307-018-00219-5
|
17 |
Yuanyuan Yang, Wei Wang, Ying Kan, Jie Liu, Jigang Yang. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney. Clinical Nuclear Medicine 2018; 43(6): 441 doi: 10.1097/RLU.0000000000002027
|
18 |
Taigo Kato, Takahiro Yoshida, Ayumu Taniguchi, Masataka Kawamura, Shigeaki Nakazawa, Tomoko Namba‐Hamano, Kazuaki Yamanaka, Toyofumi Abe, Hidefumi Kishikawa, Norio Nonomura, Ryoichi Imamura. Incidence and mortality of post‐transplant lymphoproliferative disorders after kidney transplantation: A real‐world retrospective analysis in Japan. International Journal of Urology 2022; 29(3): 206 doi: 10.1111/iju.14750
|
19 |
|
20 |
Lukas Marcelis, Charlien Berghen, Alexandra De Zutter, Pauline Biesemans, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Xavier Sagaert, Daan Dierickx, Thomas Tousseyn. Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases. Modern Pathology 2018; 31(9): 1457 doi: 10.1038/s41379-018-0054-2
|
21 |
Peter Sečník, Antonín Jabor, Petra Lavríková, Juraj Sečník, Pavlína Malíková, Eva Pokorná, Janka Franeková. Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up.. Transplant Immunology 2019; 57: 101229 doi: 10.1016/j.trim.2019.101229
|
22 |
Charlotte Lees, Maher K. Gandhi. Post-Transplant Lymphoproliferative Disorders. 2021; : 39 doi: 10.1007/978-3-030-65403-0_4
|
23 |
Alexandra Butzmann, Kaushik Sridhar, Diwash Jangam, Hanbing Song, Amol Singh, Jyoti Kumar, Karen M. Chisholm, Benjamin Pinsky, Franklin Huang, Robert S. Ohgami. Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.790481
|
24 |
Irene Faravelli, Daniele Velardo, Manuel Alfredo Podestà, Claudio Ponticelli. Immunosuppression-related neurological disorders in kidney transplantation. Journal of Nephrology 2021; 34(2): 539 doi: 10.1007/s40620-020-00956-1
|
25 |
Li Liu, Xuyan Zhang, Sizhou Feng. Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2018; 24(7): 1341 doi: 10.1016/j.bbmt.2018.02.026
|
26 |
Leticia Quintanilla-Martinez, Steven H Swerdlow, Thomas Tousseyn, Carlos Barrionuevo, Shigeo Nakamura, Elaine S. Jaffe. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Archiv 2023; 482(1): 227 doi: 10.1007/s00428-022-03414-4
|
27 |
Peter Sečník, Petra Lavríková, Lenka Hošková, Pavlína Malíková, Antonín Jabor, Janka Franeková. Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: Two year follow-up timelines and clinical correlations. Transplant Immunology 2017; 41: 22 doi: 10.1016/j.trim.2017.01.003
|
28 |
Sherif A. Rezk, Xiaohui Zhao, Lawrence M. Weiss. Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update. Human Pathology 2018; 79: 18 doi: 10.1016/j.humpath.2018.05.020
|
29 |
Meryem Colak, Shakhnoza Sarzhanova, Zeynep Arzu Yegin, Zubeyde Nur Ozkurt, Isil Fidan, Gulendam Bozdayi. Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative Disorders. Clinical Lymphoma Myeloma and Leukemia 2021; 21(5): e488 doi: 10.1016/j.clml.2021.01.023
|
30 |
Ranya Abdulovski, Dina L. Møller, Andreas D. Knudsen, Søren S. Sørensen, Allan Rasmussen, Susanne D. Nielsen, Neval E. Wareham. Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients. European Journal of Haematology 2022; 109(4): 343 doi: 10.1111/ejh.13815
|
31 |
Qing-Na Guo, Hai-Sheng Liu, Lin Li, Dian-Ge Jin, Ji-Min Shi, Xiao-Yu Lai, Li-Zhen Liu, Yan-Min Zhao, Jian Yu, Yan-Yuan Li, Fang-Quan Yu, Zhe Gao, Jiao Yan, He Huang, Yi Luo, Yi-Shan Ye. Epstein-Barr virus positive post-transplant lymphoproliferative disorder with significantly decreased T-cell chimerism early after transplantation: A case report. World Journal of Radiology 2024; 16(10): 600-607 doi: 10.4329/wjr.v16.i10.600
|
32 |
Kenneth Ofori, Craig R. Soderquist, Vundavalli V. Murty, David Park, George Vlad, Rebecca J. Leeman‐Neill, Suzanne Lentzsch, Bachir Alobeid, Govind Bhagat. The clinical and pathological features of plasma cell myeloma post solid organ transplantation. American Journal of Hematology 2020; 95(12): 1531 doi: 10.1002/ajh.25988
|
33 |
Mario L. Marques-Piubelli, Yessenia I. Salas, Carlos Pachas, Renato Becker-Hecker, Francisco Vega, Roberto N. Miranda. Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review. Pathology 2020; 52(1): 40 doi: 10.1016/j.pathol.2019.09.006
|
34 |
Anum Khaliq, Hector David Meza Comparan, Luciola Martins Frota, Ivan Da Silva. Neurocritical Care in Transplant Patients. Current Treatment Options in Neurology 2025; 27(1) doi: 10.1007/s11940-024-00815-5
|
35 |
Sarah Nikiforow, Jennifer S. Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu-Arja, Kris Michael Mahadeo, Wen-Kai Weng, Koen Van Besien, David Loeb, Sunita Dwivedy Nasta, Eneida R. Nemecek, Weizhi Zhao, Yan Sun, Faith Galderisi, Justin Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan Prockop. Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Advances 2024; 8(12): 3001 doi: 10.1182/bloodadvances.2023011626
|
36 |
Qin-Fen Xie, Ping Chen, Xin-Hua Chen, Ji-Min Liu, Jan Lerut, Shu-Sen Zheng. Gastrointestinal tract post-transplant lymphoproliferative disorder after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2017; 16(5): 556 doi: 10.1016/S1499-3872(17)60063-8
|
37 |
Michael Spiegel, Arshdeep Gujral, Binuragi Barakoti, Evan Magaliff. Abatacept-Induced Posttransplant Lymphoproliferative Disorder–Like Syndrome Without a History of Transplant. JCR: Journal of Clinical Rheumatology 2021; 27(8S): S488 doi: 10.1097/RHU.0000000000001180
|
38 |
Shivani Ghoshal. Renal and Electrolyte Disorders and the Nervous System. CONTINUUM: Lifelong Learning in Neurology 2023; 29(3): 797 doi: 10.1212/CON.0000000000001286
|
39 |
F. Montes de Jesus, D. Dierickx, V. Vergote, W. Noordzij, R. A. J. O. Dierckx, C. M. Deroose, A. W. J. M. Glaudemans, O. Gheysens, T. C. Kwee. Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00769-8
|
40 |
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019; : 593 doi: 10.1007/978-3-319-96400-3_34
|
41 |
J Tecklenborg, D Clayton, S Siebert, S M Coley. The role of the immune system in kidney disease. Clinical and Experimental Immunology 2018; 192(2): 142 doi: 10.1111/cei.13119
|
42 |
Víctor Vinuesa, Carlos Solano, Estela Giménez, David Navarro. Comparison of the artus Epstein–Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients. Diagnostic Microbiology and Infectious Disease 2017; 88(1): 36 doi: 10.1016/j.diagmicrobio.2017.02.010
|
43 |
Hong Song, Kip E. Guja, Andrei Iagaru. 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD). Seminars in Nuclear Medicine 2021; 51(4): 392 doi: 10.1053/j.semnuclmed.2020.12.009
|
44 |
Laura N. Walti, Catrina Mugglin, Daniel Sidler, Matteo Mombelli, Oriol Manuel, Hans H. Hirsch, Nina Khanna, Nicolas Mueller, Christoph Berger, Katia Boggian, Christian Garzoni, Dionysios Neofytos, Christian van Delden, Cédric Hirzel. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study. American Journal of Transplantation 2021; 21(7): 2532 doi: 10.1111/ajt.16423
|
45 |
Fernando Warley, Federico Jauk, Victoria Otero, Hernán García Rivello. Single-center “Argentine” analysis of post-transplant lymphoproliferative disorders: incidence, histopathological characteristics and EBV status. Hematology, Transfusion and Cell Therapy 2023; 45: S119 doi: 10.1016/j.htct.2022.08.005
|
46 |
Xiaohong Zhang, Wenge Hao, Tao Xu, Sha Liu, Hua Jiang. Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemia. Medicine 2017; 96(52): e9055 doi: 10.1097/MD.0000000000009055
|
47 |
Vibeke K. J. Vergote, Christophe M. Deroose, Steffen Fieuws, Wim Laleman, Ben Sprangers, Anne Uyttebroeck, Johan Van Cleemput, Gregor Verhoef, Robin Vos, Thomas Tousseyn, Daan Dierickx. Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years. Transplant International 2022; 35 doi: 10.3389/ti.2022.10707
|
48 |
Xavier Mariette, Connie Chen, Pinaki Biswas, Kenneth Kwok, Mary G. Boy. Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program. Arthritis Care & Research 2018; 70(5): 685 doi: 10.1002/acr.23421
|
49 |
Mohit Agarwal, Seyed Ali Nabavizadeh, Suyash Mohan. Chapter 6 Non–Squamous Cell Causes of Cervical Lymphadenopathy. Seminars in Ultrasound, CT and MRI 2017; 38(5): 516 doi: 10.1053/j.sult.2017.05.006
|
50 |
Claudio Annaloro, Fabio Serpenti, Giorgia Saporiti, Giulia Galassi, Francesca Cavallaro, Federica Grifoni, Maria Goldaniga, Luca Baldini, Francesco Onida. Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications. Frontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.569381
|
51 |
Nabiha B. Habib, Joseph Boss. Mycophenolate Mofetil–Induced Lymphoproliferative Disorder in a Young Adult With Chronic Posterior Uveitis. Journal of VitreoRetinal Diseases 2025; 9(2): 224 doi: 10.1177/24741264241294165
|
52 |
|
53 |
Sherif A. Rezk, Lawrence M. Weiss. EBV–Associated Lymphoproliferative Disorders. Surgical Pathology Clinics 2019; 12(3): 745 doi: 10.1016/j.path.2019.03.002
|
54 |
Philippe L. Furlano, Georg A. Böhmig, Elisabeth Puchhammer-Stöckl, Hannes Vietzen. Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation. Transplantation 2024; 108(9): 1867 doi: 10.1097/TP.0000000000004919
|
55 |
Laura J. Janke, Denise M. Imai, Heather Tillman, Rosalinda Doty, Mark J. Hoenerhoff, Jiajie J. Xu, Zachary T. Freeman, Portia Allen, Natalie Wall Fowlkes, Ilaria Iacobucci, Kirsten Dickerson, Charles G. Mullighan, Peter Vogel, Jerold E. Rehg. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts. Veterinary Pathology 2021; 58(1): 181 doi: 10.1177/0300985820970144
|
56 |
Irina Margaritescu, Aurel-Doru Chirita, Kristen Addis, Matthew S. Dinehart, Sarah Carlock, Mallory Shiver Abate, Bruce Smoller. Atlas of Dermatology, Dermatopathology and Venereology. 2022; : 477 doi: 10.1007/978-3-319-53805-1_83
|
57 |
Agata M. Bogusz. EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53. Case Reports in Hematology 2017; 2017: 1 doi: 10.1155/2017/5083463
|
58 |
Lorenzo Zaffiri, Courtney Frankel, Erika J. Bush, Megan L. Neely, Elizabeth N. Pavlisko, Irina L. Mokrova, Micah A. Luftig, Scott M. Palmer. Evidence of Epstein‐Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder. Journal of Medical Virology 2021; 93(8): 5040 doi: 10.1002/jmv.26936
|
59 |
Thomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, Tristan Wirtz, Timm Weber, Ulrike Sack, Rebecca Caeser, Jingwei Zhang, Xun Li, Van Trung Chu, Anna Jauch, Kristian Unger, Daniel J. Hodson, Altuna Akalin, Klaus Rajewsky. Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. Proceedings of the National Academy of Sciences 2020; 117(25): 14421 doi: 10.1073/pnas.1921139117
|
60 |
Stefano Fratoni, Justine M. Aziz, Carlo Gazia, Giuseppe Orlando, Andrea Tendas. Transplantation of the Pancreas. 2023; : 615 doi: 10.1007/978-3-031-20999-4_46
|